Skip to content

Efficacy of wet suction teqnique in endoscopic ultrasongraphy guided fine needle biopsy for the diagnosis of autoimmune pancreatitis using 22 gauge franseen needle: a prospective randomized-control trial.

Efficacy of wet suction teqnique in endoscopic ultrasongraphy guided fine needle biopsy for the diagnosis of autoimmune pancreatitis using 22 gauge franseen needle: a prospective randomized-control trial - Efficacy of wet suction teqnique in endoscopic ultrasongraphy guided fine needle biopsy for the diagnosis of autoimmune pancreatitis using 22 gauge franseen needle: a prospective randomized-control trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042396
Enrollment
26
Registered
2020-11-10
Start date
2020-11-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune pancreatitis type 1

Interventions

EUS-FNB with wet suction technique Conventional EUS-FNB without wet suction technique

Sponsors

Fukushima Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Elevated serum IgG4 (no less thatn 135 mg/dl 2. The cases who show pancreatic swelling by echo, CT, MRI, etc.... and who are thought to be AIP.

Exclusion criteria

Exclusion criteria: 1. Elevated serum IgG4 are not observed. 2. The cases who have already been administered steroid and whose IgG4, disease have been already improved. 3. The cases who can't be performed EUS-FNA (difficult to insert scope, bleeding tendency). 4. The cases who can't stop antithrombotic according to the gastroinert endoscopy guideline. d. The cases who were not sufficiently sedated. e. The cases who disagree with this RCT.

Design outcomes

Primary

MeasureTime frame
The cases who show Level 1 or Level 2 histlogical findings that were difinited in 2010 International Consensus Diagnostic criteria of AIP.

Secondary

MeasureTime frame
1. The cases who show Level 1 histlogical findings that were difinited in 2010 International Consensus Diagnostic criteria of AIP. 2. The cases who show each four histlogical findings that were difinited in 2010 International Consensus Diagnostic criteria of AIP. These findings are (1) Lymphoplasmacytic infiltrate without granulocytic infiltration (2) Obliterative phlebitis (3) Storiform fibrosis (4) Abundant (> 10 cells/HPF) IgG4 positive cells 3. Adverse events 4. The cases who are obtained histological specimen 5. Number of punctures 6. The cases whose specimen is sufficient for immunostain

Countries

Japan

Contacts

Public ContactMitsuru Sugimoto

Fukushima Medical University, School of Medicine Department of Gastroenterology

kita335@fmu.ac.jp+81-24-547-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026